The Cervical Spacer Systems Market size is projected to be valued at USD 382.7 million in 2023 and is expected to rise to USD 744.2 million by 2033. The sales of cervical spacer systems are expected to register a significant CAGR of 6.9% during the forecast period.
The market's growth can be attributed to rising rates of obesity, joint pain, numbness in the legs and arms, and decreased range of motion.
According to the WHO factsheet, nearly 1.9 billion adults were overweight in 2018, and about 10 to 15% of adults over 60 have some degree of osteoarthritis. The population is expected to reach 130 million by 2050. Because of the alarming increase, governments and non-governmental organizations (NGOs) are working together to combat the situation.
The Osteoarthritis Action Alliance (OAAA) launched a new campaign called StandUp2OA in 2018 to raise awareness about osteoarthritis. As a result of such factors, the industry is expected to grow significantly during the forecast period.
Attributes | Details |
---|---|
Market CAGR | 6.9% |
Market Valuation (2023) | USD 382.7 million |
Market Valuation (2033) | USD 744.2 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global demand for cervical spacer systems is projected to increase at a CAGR of 6.9% during the forecast period between 2023 and 2033, reaching a total of USD 744.2 million in 2033, according to a report from Future Market Insights (FMI). From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 5.5%.
Cervical cancer is becoming increasingly common across the world. This is mostly due to changes in lifestyle and food choices. This, in turn, is increasing demand for cervical spacer systems, which aid in the early detection and treatment of the condition.
People are becoming more aware of cervical cancer and its signs. This has resulted in an upsurge in women requesting screening tests for early detection of the disease. Cervical spacer systems are critical in the identification and treatment of cervical cancer.
Technological advances are assisting manufacturers in developing novel items that are easier to use and produce better results than traditional approaches for identifying or treating cervical abnormalities or malignancies. This is boosting the worldwide Cervical Spacer Systems market forward.
Increased funding from private and public sectors to boost the Market
Increased funding from private and public sectors is expected to benefit the global cervical spacer systems market during the forecast period. The Journal of Stem Cells published a new approach to treating osteoarthritis with mesenchyme stem cell therapy in 2018. Additionally, the FDA's increasing approval of drugs is expected to be a significant factor in strengthening the global cervical systems market.
For example, the United States Food and Drug Administration accepted the regulatory submission for Tanezumab, which is used to relieve chronic pain caused by moderate to severe osteoarthritis, in March 2020. Similarly, Orthofix Medical Inc., a well-established provider of medical devices for the spine and extremities, disclosed the FDA 510(k) clearance for the first patient implant of the 3D-printed CONSTRUX Mini Ti Spacer System in April 2021.
The COSTRUX Mini Ti cervical spacer with NanovateTM Technology is Orthofix's first 3D-printed titanium interbody, and it aims to improve anterior cervical discectomy fusion (ACDF) procedures. Because of these favorable factors, the market is expected to grow significantly during the forecast period.
High Cost of Drugs to Impede Market Growth
The high cost of drugs is expected to be a significant factor impeding market growth during the forecast period. Furthermore, risks associated with the use of nonsteroidal anti-inflammatory drugs, such as allergic reactions and stomach ulcers, are expected to be another impediment to market expansion in the near future.
However, with the increased launch of new products, the market is expected to grow in size in the near future. For example, in April 2017, Life Spine, Inc. introduced the PLATEAU-C Ti, which may improve in-situ visibility and bone graft containment. As a result, the market is likely to achieve balance and may see growth opportunities during the forecast period.
Rapid Technological Advancements in the Region's Healthcare to Boost Market Growth
According to the analysis, North America is anticipated to dominate the global cervical spacer market during the forecast period. In 2022, North America was expected to garner 34.8% of the global market share.
The United States is expected to make maximum contribution of 30.8% in developing the market during the forecast period. Rapid technological advancement in the region's healthcare sector is another salient factor contributing to the market growth. Other factors like the increasing geriatric population, ongoing R&D in the field, and others are likely to benefit the industry growth in the assessment period.
Growing FDA approvals are anticipated to play a key role in developing the regional market during the forecast period. For instance, in May 2021, ChoiceSpine LLC, a private spinal device manufacturer based in Knoxville, TN, obtained clearance from the United States FDA to market the Blackhawk Ti Cervical Spacer System. Owing to the aforementioned factors, the regional market is likely to dominate the global market throughout the forecast period.
Availability of Advanced Research Activities for Drug Development in the Region to Augment Market Growth
Europe is projected to be the second-leading market during the forecast period. As per the analysis, in 2022, the region is expected to claim 29.3% of the global market share. Countries such as the United Kingdom, Sweden, and Germany are anticipated to make the maximum contribution to developing the market during the forecast period.
Expansion of the regional market can be attributed to the availability of advanced research activities for drug development. Other favorable factors include the presence of key players, approval of products, and ongoing development in the regional healthcare sector.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The 12x12mm Category to Have a Huge Demand in the Global Market
The global cervical spacer systems market is divided into four types: 12x12mm, 12x14mm, 14x16mm, and 16x18mm. Because of its low cost and simple availability, the 12x12mm category is predicted to account for the highest proportion of 43.2% in the global cervical spacer systems market during the forecast period.
Cervical spacer devices with dimensions of 12x12mm are utilized in surgical procedures to help preserve spine stability during operation. It is essential equipment that assists in keeping the patient's head, neck, and spinal cord off the table while surgery is being performed on them.
A medical device measuring 12x14mm is utilized in cervical spacer systems. It is also known as an interbody decompression plate or cervical disc space maintainer. The 12x14mm device is made up of two metal plates joined by screws and is intended to relieve pressure on the spinal cord caused by excessive neck movement during sleeping. The 12 x 14 mm devices are most frequently utilized in laminectomy patients.
Metal or Alloy Cervical Spacer Systems Hold a Significant Share of 72.5% of the Market
These spacer systems, made from metal or alloy materials, are widely used in cervical spine stabilization and fusion procedures. The use of metal or alloy cervical spacer systems offers advantages such as excellent biomechanical properties, durability, and stability, making them suitable for various cervical spine conditions.
Surgeons often prefer metal or alloy spacer systems for their ability to provide sufficient support and maintain proper spacing between cervical vertebrae during fusion surgeries. The growing adoption of these spacer systems in medical facilities, coupled with ongoing research and development efforts by manufacturers to enhance their design and functionality, further contributes to their prominent share in the cervical spacer systems market.
Key startup players in the Cervical Spacer Systems market are Smart Load Solutions, Carbontec, Themo, Durocan, OTREMA, and Tepeo. Some of the emerging players in the global cervical spacer systems market include Elsa, Living With, Citryll, TruStem Cell Therapy, Cyxone, Re.Flex, Protagen, InnVentis, Galapagos, and Simplify Medical.
The emergence of new market players and their contributions to market strengthening is significant for the industry. Simplify Medical, for example, raised around USD 21 million in July 2017 to support two ongoing trials of its cervical disc implant in the United States.
The company designed the disc to be visible on MRI to avoid radiation exposure from CT scans. Such contributions from emerging businesses are expected to boost market growth during the forecast period.
Life Spine, Inc., Exactech, Inc., Biomet, Inc., Stryker, Zimmer Inc., Paonan Biotech Co., Ltd., Nexxt Spine, LLC, and Orthofix Holdings, Inc. are key participants in the worldwide cervical spacer systems market.
Recent Developments in The Global Cervical Spacer Systems Market
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | USD million for Value |
Key Countries Covered | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
Key Segments Covered | Spacer, Material Used, Region |
Key Companies Profiled | Life Spine, Inc.; Exactech, Inc.; Stryker Corporation; Zimmer Biomet Holdings Inc.; Paonan Biotech Co., Ltd.; Nexxt Spine, LLC; Orthofix Holdings, Inc. |
Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing | Available upon Request |
The market is forecast to register a CAGR of 6.9% through 2033.
The market is valued to hit USD 744.2 million by 2033.
The global market advanced at a 5.5% CAGR from 2018 to 2022.
The market is estimated to secure a valuation of USD 382.7 million in 2023.
The 12x12mm segment, accounts for a substantial share of the global market at 43.2%.
34.8% of the global market is set to be dominated by North America.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Spacer 5.1. 12x12mm 5.2. 12x14mm 5.3. 14x16mm 5.4. 16x18mm 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material Used 6.1. PEEK Radiolucent Polymer Cervical Spacer Systems 6.2. Metal or Alloy Cervical Spacer Systems 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Western Europe 7.4. Eastern Europe 7.5. South Asia and Pacific 7.6. East Asia 7.7. Middle East and Africa 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Key Countries Market Analysis 16. Market Structure Analysis 17. Competition Analysis 17.1. Life Spine, Inc. 17.2. Exactech, Inc. 17.3. Stryker Corporation 17.4. Zimmer Biomet Holdings Inc. 17.5. Paonan Biotech Co., Ltd. 17.6. Nexxt Spine, LLC 17.7. Orthofix Holdings, Inc. 17.8. Biomet, Inc. 17.9. Globus Medical Inc. 17.10. Spinal Elements Holdings Inc. 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports